# Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

> **NCT05179967** · NA · UNKNOWN · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 106 (estimated)

## Conditions studied

- Juxtarenal Abdominal Aortic Aneurysm

## Interventions

- **DEVICE:** WeFlow-JAAA Stent Graft System

## Key facts

- **NCT ID:** NCT05179967
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-23
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179967, "Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05179967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*